79°F

Home Health House Calls: Inhaled Insulin

In this edition of home health house calls we learn about a inhaled insulin called Afrezza.
Welcome to Home Health House Calls.

The FDA has approved an inhaled insulin called Afrezza.
Now people will have another treatment option for Type 1 or Type 2 Diabetes.
It is a rapid acting insulin that is taken before each meal, with no needles required.
It is not to replace the need for injected long-acting insulin for those who need it.
It is inhaled and is said to be absorbed more quickly and in a different way.
From the time you inhale it to the time it peaks is about 15 to 20 minutes according to Keith Campbell, Professor at Washington State University College of Pharmacy.
The FDA approved the safety and effectiveness based on about 3000 people including 1,000 with Type 1 Diabetes and about 2,000 with type 2.
According to the FDA, the most commonly reported side effects were low blood sugar, cough, and throat pain or irritation.
Inhaled insulin is not recommended for people with asthma or COPD or for smokers.
This medication will not be appropriate for all diabetics.
If interested you should discuss the medication with your healthcare provider.

Page: [[$index + 1]]
comments powered by Disqus